When was Inozyme Pharma, Inc. stock made available for the first time to the public?

The IPO Date for Inozyme Pharma, Inc. is 2020-07-24. On this 2020-07-24, Inozyme Pharma, Inc. stock was made publicly available.

Where is the headquarters of Inozyme Pharma, Inc. stock?

Headquarters of Inozyme Pharma, Inc. is in US at 321 Summer Street, Boston, MA 02210.

What industry does Inozyme Pharma, Inc. belong to?

The Inozyme Pharma, Inc. belongs to Biotechnology.

Inozyme Pharma, Inc.

INZY•NASDAQ

Healthcare

Biotechnology

$4.00

$0.010(0.25%)

Inozyme Pharma, Inc. (INZY) Company Profile & Overview

Explore Inozyme Pharma, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Inozyme Pharma, Inc. (INZY) Company Profile & Overview

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

SectorHealthcare

IndustryBiotechnology

CEODr. Douglas A. Treco Ph.D.

Contact Information

https://www.inozyme.com

857 330 4340

321 Summer Street, Boston, MA, 02210

Company Facts

67 Employees

IPO DateJul 24, 2020

CountryUS

Actively Trading

Frequently Asked Questions

;